rs397514040
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000379802.8(DSP):βc.6091_6092delβ(p.Leu2031GlyfsTer29) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,878 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. S2030S) has been classified as Likely benign.
Frequency
Consequence
ENST00000379802.8 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.6091_6092del | p.Leu2031GlyfsTer29 | frameshift_variant | 24/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001008844.3 | c.4294_4295del | p.Leu1432GlyfsTer29 | frameshift_variant | 24/24 | NP_001008844.1 | ||
DSP | NM_001319034.2 | c.4762_4763del | p.Leu1588GlyfsTer29 | frameshift_variant | 24/24 | NP_001305963.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.6091_6092del | p.Leu2031GlyfsTer29 | frameshift_variant | 24/24 | 1 | NM_004415.4 | ENSP00000369129 | P2 | |
DSP | ENST00000418664.2 | c.4294_4295del | p.Leu1432GlyfsTer29 | frameshift_variant | 24/24 | 1 | ENSP00000396591 | A2 | ||
DSP | ENST00000710359.1 | c.4762_4763del | p.Leu1588GlyfsTer29 | frameshift_variant | 24/24 | ENSP00000518230 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461878Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 727240
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 08, 2024 | The c.6091_6092del (p.Leu2031Glyfs*29) variant of DSP is in the last exon (exon 24) of the gene and is predicted to alter the protein amino acid sequence beginning at position 2031, leading to a premature termination codon 29 amino acids downstream. This termination codon occurs within the last exon and is likely to escape nonsense mediated decay (NMD) and result in a truncated protein that misses >10% of the coding region. This variant has been observed in trans with another disease-causing variant in an individual diagnosed with Carvajal syndrome based on phenotypes including woolly hair, striate PPK, and left-dominant arrhythmogenic cardiomyopathy (PMID: 31073624). Also, this variant was found in combination with another truncating mutation in an individual with severe fragility of skin and mucous membranes (PMID: 16175511). In addition, multiple other C-terminal truncating variants downstream of the amino acid 2031 in the DSP gene, p.Arg2284*, p.Gln2667*, p.Gln2730Serfs*16, have been reported in individuals with ARVC/D or DCM (PMID: 20400443, 27194543, 27532257). This variant is absent in the general population (gnomAD). Therefore, the c.6091_6092del (p.Leu2031Glyfs*29) variant of DSP is classified as pathogenic. - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | This sequence change creates a premature translational stop signal (p.Leu2031Glyfs*29) in the DSP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 841 amino acid(s) of the DSP protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autosomal recessive Carvajal syndrome (PMID: 31073624). This variant has been reported in individual(s) with autosomal recessive lethal acantholytic epidermolysis bullosa (PMID: 16175511); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 16844). This variant disrupts a region of the DSP protein in which other variant(s) (p.Gln2667*) have been determined to be pathogenic (PMID: 20400443, 27194543). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Lethal acantholytic epidermolysis bullosa Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2005 | - - |
Arrhythmogenic right ventricular dysplasia 8 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | Nov 14, 2023 | The c.6091_6092del (p.Leu2031Glyfs*29) variant of DSP is in the last exon (exon 24) of the gene and is predicted to alter the protein amino acid sequence beginning at position 2031, leading to a premature termination codon 29 amino acids downstream. This termination codon occurs within the last exon and is likely to escape nonsense mediated decay (NMD) and result in a truncated protein that misses >10% of the coding region. This variant has been observed in trans with another disease-causing variant in an individual diagnosed with Carvajal syndrome based on phenotypes including woolly hair, striate PPK, and left-dominant arrhythmogenic cardiomyopathy (PMID: 31073624). Also, this variant was found in combination with another truncating mutation in an individual with severe fragility of skin and mucous membranes (PMID: 16175511). In addition, multiple other C-terminal truncating variants downstream of the amino acid 2031 in the DSP gene, p.Arg2284*, p.Gln2667*, p.Gln2730Serfs*16, have been reported in individuals with ARVC/D or DCM (PMID: 20400443, 27194543, 27532257). This variant is absent in the general population (gnomAD). Therefore, the c.6091_6092del (p.Leu2031Glyfs*29) variant of DSP is classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 22, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31073624, 34998950, 16175511) - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 09, 2024 | The c.6091_6092delTT pathogenic mutation, located in coding exon 24 of the DSP gene, results from a deletion of two nucleotides at nucleotide positions 6091 to 6092, causing a translational frameshift with a predicted alternate stop codon (p.L2031Gfs*29). This alteration occurs at the 3' terminus of theDSP gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 29% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). Furthermore, this alteration has been reported in the compound heterozygous state in a neonate with lethal acantholytic epidermolysis bullosa (Jonkman MF et al. Am. J. Hum. Genet. 2005;77:653-60). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Woolly hair-skin fragility syndrome;C1843896:Arrhythmogenic right ventricular dysplasia 8;C1852127:Keratosis palmoplantaris striata 2;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma;C1864826:Lethal acantholytic epidermolysis bullosa;C4014393:Cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 16, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at